Biochemical blood studies in patients with ovarian carcinoma treated with C-283. 3. Immunoelectrophoresis of serum proteins.
D000166:Acridines / Q000627:therapeutic use*; D000510:Alpha-Globulins / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001201:Ascites; D001798:Blood Proteins / Q000032:analysis*; D005260:Female; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D008744:Methylamines / Q000627:therapeutic use; D009574:Nitro Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000097:blood* / Q000188:drug therapy; D011437:Propylamines / Q000627:therapeutic use; D012709:Serum Albumin / Q000032:analysis; D014168:Transferrin / Q000032:analysis
D000166:Acridines; D000510:Alpha-Globulins; D000970:Antineoplastic Agents; D001798:Blood Proteins; D006242:Haptoglobins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007136:Immunoglobulins; D008744:Methylamines; D009574:Nitro Compounds; D011437:Propylamines; D012709:Serum Albumin; D014168:Transferrin